Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for GRN-1201 with pembrolizumab is displayed, including study details, participation criteria, locations, and outcome measures. The record indicates that the study was terminated because recruitment was too slow.
    Difference
    51%
    Check dated 2026-11-11T19:18:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T19:57:24.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T20:48:48.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-14T20:50:45.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T21:35:36.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link. The previous study record content appears to be removed or hidden.
    Difference
    18%
    Check dated 2026-09-23T21:42:15.000Z thumbnail image

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.